Differences in Disease Severity but Similar Telomere Lengths in Genetic Subgroups of Patients with Telomerase and Shelterin Mutations
2011

Differences in Disease Severity but Similar Telomere Lengths in Genetic Subgroups of Patients with Telomerase and Shelterin Mutations

Sample size: 194 publication 10 minutes Evidence: high

Author Information

Author(s): Vulliamy Tom J., Kirwan Michael J., Beswick Richard, Hossain Upal, Baqai Charlotte, Ratcliffe Anna, Marsh Judith, Walne Amanda, Dokal Inderjeet

Primary Institution: Queen Mary University of London

Hypothesis

How do telomere lengths and disease severity differ among genetic subgroups of patients with dyskeratosis congenita and related syndromes?

Conclusion

The study found that while there are differences in disease severity among genetic subgroups, telomere lengths do not vary significantly between these groups.

Supporting Evidence

  • 24 novel mutations were identified in telomerase and shelterin components.
  • Patients with DKC1 and TINF2 mutations present at a younger age and have more disease features than those with TERC or TERT mutations.
  • There is no difference in telomere length between the different genetic subtypes.
  • The incidence of aplastic anemia is greater in patients with TERC or TINF2 mutations compared to those with DKC1 mutations.
  • Cancer incidence is highest in patients with TERC mutations.

Takeaway

This study looked at patients with a disease related to telomeres and found that even though some groups had more severe symptoms, their telomeres were all about the same length.

Methodology

The study involved screening for mutations in telomere-related genes among patients and comparing clinical features, telomere lengths, and mutation status.

Potential Biases

Potential bias due to the selection of patients referred to a specific registry.

Limitations

The study focused only on index cases and did not account for asymptomatic individuals, which may affect the generalizability of the findings.

Participant Demographics

Patients included were genetically characterized index cases with various forms of bone marrow failure syndromes.

Statistical Information

P-Value

0.04

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0024383

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication